The Swiss ETH spin off Akina receives CHF 1,6 million in pre seed capital. Incorporated by two former members of the SMS Lab, Florian Haufe and Michele Xiloyannis in 2021 after years of research in the areas of rehabilitation technology and robotics, the startup develops intelligent medical software to support patients in independent physiotherapy. Akina […]
The Zurich based aspaara has raised CHF 2 million in their seed financing round to build the next generation ERP that is finally human-centric. The start up aspaara is an Artificial Intelligence (AI) platform that optimises
Credit Suisse Group has announced that its board of directors will propose to an Extraordinary General Meeting to be held on 23 November 2022 to approve two separate share capital increases: a first capital increase through the
Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies, a privately owned Swiss company spun out from EPFL. The financing was realised in form of private bonds with warrants which can be
Last September Cornèr Banca has established a CHF 1 billion Covered Bond Programme. The Covered Bonds benefit from a guarantee issued by its subsidiary Accent Ipoteche, indirectly secured by a pool of Swiss residential and
Banking & Finance
Deal & transactions
Lenz & Staehelin: Caceis to acquire European asset servicing activities
CACEIS, the asset servicing banking group of Crédit Agricole and Santander, and Royal Bank of Canada (RBC) has announced that they have signed a Memorandum of Understanding with a view for CACEIS to acquire
Insmed Incorporated, a global biopharmaceutical company, closed a million strategic financing. The company has announced three strategic financings resulting in aggregate gross proceeds of USD 775 million. Proceeds from the transactions will strengthen Insmed’s financial
Accelleron Industries and Turbo Systems Schweiz have entered into a CHF 450 m credit facilities agreement with Credit Suisse Switzerland as mandated lead arranger, agent and original lender. Based in Baden, Accelleron is a renowed company
BGPartner has advised Araris Biotech in a CHF 24 million financing round, involving the two co-lead investors 4BIO Capital and Pureos Bioventures. Araris Biotech, a company pioneering antibody-drug conjugate (ADC) linker technology, intends to use the
Walder Wyss has advised Swiss Life and Swiss Life Holding on its new CHF 500 million syndicated revolving credit facility with UBS Switzerland as agent, coordinator, mandated lead arranger and lender and Credit Suisse Switzerland, Deutsche
